Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy

Materials Science and Engineering C

Volumn 71, Issue , 2017, Pages 1231-1240

  Wang, Meili ^a   Zhao, Tingting ^a   Liu, Yanping ^a   Wang, Qianqian ^a   Xing, Shanshan ^a   Li, Lei ^a   Wang, Longgang ^a   Liu, Lanxiang ^b   Gao, Dawei ^a  

^a YANSHAN UNIVERSITY   (China)

^b FIRST HOSPITAL OF QINHUANGDAO   (China)

Author keywords

Antitumor; Chitosan; Liposomes; pH responsive release; Ursolic acid

Indexed keywords

CARBOXYLIC ACIDS; CELL DEATH; CELL PROLIFERATION; CHITIN; CHITOSAN; CYTOLOGY; DRUG DOSAGE; HISTOLOGY; LIPOSOMES; MAMMALS; TISSUE;

ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; ANTIPROLIFERATIVE EFFECT; ANTITUMOR DRUG DELIVERIES; DRUG CONTROLLED RELEASE; PH-RESPONSIVE; PROLIFERATION ACTIVITY; URSOLIC ACID;

TUMORS;

ANTINEOPLASTIC AGENT; CHITOSAN; LIPOSOME; TRITERPENE; URSOLIC ACID;

ANIMAL; CHEMISTRY; DRUG SCREENING; HELA CELL LINE; HUMAN; METABOLISM; MOUSE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PH;

ANIMALS; ANTINEOPLASTIC AGENTS; CHITOSAN; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICE; NEOPLASMS, EXPERIMENTAL; TRITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85006251497     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.11.014     Document Type: Review

References (44)

1. [1] Zhao, T., Liu, Y., Gao, Z., Gao, D., Li, N., Bian, Y., Dai, K., Liu, Z., Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Mater. Sci. Eng. C 53 (2015), 196–203.
2. [2] Yang, F.Y., Wong, T.T., Teng, M.C., Liu, R.S., Lu, M., Liang, H.F., Wei, M.C., Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J. Control. Release 160 (2012), 652–658.
3. [3] Yu, M., Guo, F., Tan, F., Li, N., Dual-targeting nanocarrier system based on thermosensitive liposomes and gold nanorods for cancer thermo-chemotherapy. J. Control. Release 215 (2015), 91–100.
4. [4] Liu, Y., Gao, D., Zhang, X., Liu, Z., Dai, K., Ji, B., Wang, Q., Luo, L., Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Mater. Sci. Eng. C 64 (2016), 124–132.
5. [5] Zhang, X., Li, N., Liu, Y., Ji, B., Wang, Q., Wang, M., Dai, K., Gao, D., On-demand drug release of ICG-liposomal wedelolactone combined photothermal therapy for tumor. Nanomedicine, 2016, 10.1016/j.nano.2016.05.013.
6. [6] Luo, L., Bian, Y., Liu, Y., Zhang, X., Wang, M., Xing, S., Li, L., Gao, D., Combined Near Infrared Photothermal Therapy and Chemotherapy Using Gold Nanoshells Coated Liposomes to Enhance Antitumor Effect, Small. 2016, 10.1002/smll.201503961.
7. [7] Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C., Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5 (2008), 505–515.
8. [8] Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000), 271–284.
9. [9] Farokhzad, O.C., Langer, R., Impact of nanotechnology on drug delivery. ACS Nano 3 (2009), 16–20.
10. [10] Mady, M.M., Darwish, M.M., Khalil, S., Khalil, W.M., Biophysical studies on chitosan-coated liposomes. Eur. Biophys. J. 38 (2009), 1127–1133.
11. [11] Zhu, J., Liao, L., Bian, X., Kong, J., Yang, P., Liu, B., pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres. Small 8 (2012), 2715–2720.
12. [12] Yan, L., Crayton, S.H., Thawani, J.P., Amirshaghaghi, A., Tsourkas, A., Cheng, Z., A pH-responsive drug-delivery platform based on glycol chitosan-coated liposomes. Small 11 (2015), 4870–4874.
13. [13] Yang, H.Y., Jang, M.-S., Gao, G.H., Lee, J.H., Lee, D.S., Construction of redox/pH dual stimuli-responsive PEGylated polymeric micelles for intracellular doxorubicin delivery in liver cancer. Polym. Chem. 7 (2016), 1813–1825.
14. [14] Liu, Z., Sun, X., Nakayama-Ratchford, N., Dai, H., Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 1 (2007), 50–56.
15. [15] She, W., Luo, K., Zhang, C., Wang, G., Geng, Y., Li, L., He, B., Gu, Z., The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy. Biomaterials 34 (2013), 1613–1623.
16. [16] Wilson, B., Samanta, M.K., Santhi, K., Kumar, K.P., Ramasamy, M., Suresh, B., Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 6 (2010), 144–152.
17. [17] Rao, W., Wang, H., Han, J., Zhao, S., Dumbleton, J., Agarwal, P., Zhang, W., Zhao, G., Yu, J., Zynger, D.L., Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells. ACS Nano 9 (2015), 5725–5740.
18. [18] Xie, Y.T., Du, Y.Z., Yuan, H., Hu, F.Q., Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system. Int. J. Nanomedicine 7 (2012), 3235–3244.
19. [19] Ikeda, Y., Murakami, A., Ohigashi, H., Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol. Nutr. Food Res. 52 (2008), 26–42.
20. [20] Yang, G., Yang, T., Zhang, W., Lu, M., Ma, X., Xiang, G., In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. J. Agric. Food Chem. 62 (2014), 2207–2215.
21. [21] Shanmugam, M.K., Dai, X., Kumar, A.P., Tan, B.K., Sethi, G., Bishayee, A., Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem. Pharmacol. 85 (2013), 1579–1587.
22. [22] Kassi, E., Papoutsi, Z., Pratsinis, H., Aligiannis, N., Manoussakis, M., Moutsatsou, P., Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J. Cancer Res. Clin. Oncol. 133 (2007), 493–500.
23. [23] De Angel, R.E., Smith, S.M., Glickman, R.D., Perkins, S.N., Hursting, S.D., Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr. Cancer 62 (2010), 1074–1086.
24. [24] Hsu, Y.L., Kuo, P.L., Lin, C.C., Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci. 75 (2004), 2303–2316.
25. [25] Cerga, O., Borcan, F., Ambrus, R., Popovici, I., Syntheses of new cyclodextrin complexes with oleanolic and ursolic acids. J. Agroaliment. Process. Technol. 17 (2011), 405–409.
26. [26] Lopes, S.C., Novais, M.V., Ferreira, D.S., Braga, F.C., Magalhaes-Paniago, R., Malachias, A., Oliveira, M.C., Ursolic acid incorporation does not prevent the formation of a non-lamellar phase in pH-sensitive and long-circulating liposomes. Langmuir 30 (2014), 15083–15090.
27. [27] Bian, Y., Gao, D., Liu, Y., Li, N., Zhang, X., Zheng, R.Y., Wang, Q., Luo, L., Dai, K., Preparation and study on anti-tumor effect of chitosan-coated oleanolic acid liposomes. RSC Adv. 5 (2015), 18725–18732.
28. [28] Zhang, Z., Wang, J., Nie, X., Wen, T., Ji, Y., Wu, X., Zhao, Y., Chen, C., Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods. J. Am. Chem. Soc. 136 (2014), 7317–7326.
29. [29] Song, J., Yang, X., Jacobson, O., Lin, L., Huang, P., Niu, G., Ma, Q., Chen, X., Sequential drug release and enhanced photothermal and photoacoustic effect of hybrid reduced graphene oxide-loaded ultrasmall gold nanorod vesicles for cancer therapy. ACS Nano 9 (2015), 9199–9209.
30. [30] Liu, Y., Liu, D., Zhu, L., Gan, Q., Le, X., Temperature-dependent structure stability and in vitro release of chitosan-coated curcumin liposome. Food Res. Int. 74 (2015), 97–105.
31. [31] Liang, X., Mao, G., Ng, K.Y., Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J. Colloid Interface Sci. 278 (2004), 53–62.
32. [32] Avadi, M.R., Sadeghi, A.M., Mohammadpour, N., Abedin, S., Atyabi, F., Dinarvand, R., Rafiee-Tehrani, M., Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine 6 (2010), 58–63.
33. [33] Guo, J., Chitosan-coated liposomes: characterization and interaction with leuprolide. Int. J. Pharm. 260 (2003), 167–173.
34. [34] Wang, Q., Lv, S., Lu, J., Jiang, S., Lin, L., Characterization, stability, and in vitro release evaluation of carboxymethyl chitosan coated liposomes containing fish oil. J. Food Sci. 80 (2015), C1460–C1467.
35. [35] Peng, H., Li, W., Ning, F., Yao, L., Luo, M., Zhu, X., Zhao, Q., Xiong, H., Amphiphilic chitosan derivatives-based liposomes: synthesis, development, and properties as a carrier for sustained release of salidroside. J. Agric. Food Chem. 62 (2014), 626–633.
36. [36] Grant, J., Blicker, M., Piquette-Miller, M., Allen, C., Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel. J. Pharm. Sci. 94 (2005), 1512–1527.
37. [37] Panwar, P., Pandey, B., Lakhera, P., Singh, K., Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomedicine, 5, 2010, 101.
38. [38] Hardiansyah, A., Huang, L.-Y., Yang, M.-C., Purwasasmita, B.S., Liu, T.-Y., Kuo, C.-Y., Liao, H.-L., Chan, T.-Y., Tzou, H.-M., Chiu, W.-Y., Novel pH-sensitive drug carriers of carboxymethyl-hexanoyl chitosan (Chitosonic® acid) modified liposomes. RSC Adv. 5 (2015), 23134–23143.
39. [39] Wang, H., Di, J., Sun, Y., Fu, J., Wei, Z., Matsui, H., Alonso, A.d.C., Zhou, S., Biocompatible PEG-chitosan@carbon dots hybrid nanogels for two-photon fluorescence imaging, near-infrared light/pH dual-responsive drug carrier, and synergistic therapy. Adv. Funct. Mater. 25 (2015), 5537–5547.
40. [40] Stefanadis, C., Chrysochoou, C., Markou, D., Petraki, K., Panagiotakos, D.B., Fasoulakis, C., Kyriakidis, A., Papadimitriou, C., Toutouzas, P.K., Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. J. Clin. Oncol. 19 (2001), 676–681.
41. [41] Lu, J., Zhao, W., Huang, Y., Liu, H., Marquez, R., Gibbs, R.B., Li, J., Venkataramanan, R., Xu, L., Li, S., Li, S., Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Mol. Pharm. 11 (2014), 4164–4178.
42. [42] Du, H., Liu, M., Yang, X., Zhai, G., The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery. Drug Discov. Today 20 (2015), 1004–1011.
43. [43] Thanou, M., Verhoef, J.C., Junginger, H.E., Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52 (2001), 117–126.
44. [44] Nagpal, K., Singh, S.K., Mishra, D.N., Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety. Int. J. Biol. Macromol. 59 (2013), 72–83.